New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 9, 2013
16:25 EDTPKIPerkinElmer rises over 4% after Verinata pact on prenatal test
PerkinElmer (PKI) traded up today after announcing a collaboration this morning with Verinata Health to expand access to the non-invasive prenatal test for Down syndrome and other chromosomal abnormalities. Under the terms of the collaboration agreement, PerkinElmer will serve as an exclusive Verinata Health commercial partner in the joint sales and marketing of the test in the United States. The collaboration consolidates and streamlines delivery of prenatal testing options due to the combination of PerkinElmer’s extensive prenatal testing menu with Verinata’s proprietary technologies for the early, non-invasive identification of specific fetal chromosomal aneuploidies. PerkinElmer shares closed up $1.34, or 4.06%, to $34.36.
News For PKI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
08:34 EDTPKIPerkinElmer selloff a buying opportunity, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier recommends investors buy PerkinElmer following the recent pullback in shares. The stock is down 18% over the last month and is now one of the most attractively valued tools companies, Brokmeier tells investors in a research note. He keeps a Buy rating on the name with a $59 price target.
08:21 EDTPKIPerkinElmer weakness creates buying opportunity, says Cantor
Subscribe for More Information
February 4, 2016
16:30 EDTPKIPerkinElmer sees FY16 adjusted EPS $2.65-$2.75, consensus $2.82
Subscribe for More Information
16:29 EDTPKIPerkinElmer reports Q4 adjusted EPS 86c, consensus 87c
Reports Q4 revenue $608.1M, consensus $617.52M.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use